← Open Payments lookup

STEPHANIE SMITH: Open Payments

NPI 1720563596 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,289 in 116 payments from 17 companies in 2025. Trend: 2023 $1,508 · 2024 $1,514 · 2025 $2,289

Food & beverage: $2,289
CompanyPaymentsAmount
ABBVIE INC.17$251
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$229
GENZYME CORPORATION11$226
Ardelyx, Inc.12$215
Aimmune Therapeutics, Inc.11$209
Phathom Pharmaceuticals, Inc.6$195
Gilead Sciences, Inc.8$188
Madrigal Pharmaceuticals6$183
Takeda Pharmaceuticals U.S.A., Inc.8$145
QOL Medical, LLC5$117

Products named: DUPIXENT, XIFAXAN, IBSRELA, ZENPEP, VOQUEZNA, REZDIFFRA, Sucraid, ENTYVIO.

Industry payments across MS — which companies pay providers there.